Radiation therapy to the primary in metastatic prostate cancer: palliation only or altering tumor biology? |
journalArticle |
2017 |
Blanchard, P.; Bossi, A.; Fizazi, K. |
Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experience |
journalArticle |
2018 |
Fayard, F.; Petit, C.; Lacas, B.; Pignon, J. P. |
Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement |
journalArticle |
2015 |
Stewart, L. A.; Clarke, M.; Rovers, M.; Riley, R. D.; Simmonds, M.; Stewart, G.; Tierney, J. F.; Group, Prisma-Ipd Development |
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours |
journalArticle |
2015 |
Levy, C.; Allouache, D.; Lacroix, J.; Dugue, A. E.; Supiot, S.; Campone, M.; Mahe, M.; Kichou, S.; Leheurteur, M.; Hanzen, C.; Dieras, V.; Kirova, Y.; Campana, F.; Le Rhun, E.; Gras, L.; Bachelot, T.; Sunyach, M. P.; Hrab, I.; Geffrelot, J.; Gunzer, K.; Constans, J. M.; Grellard, J. M.; Clarisse, B.; Paoletti, X. |
Age at start of using tobacco on the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium (INHANCE) |
journalArticle |
2019 |
Chang, C. P.; Chang, S. C.; Chuang, S. C.; Berthiller, J.; Ferro, G.; Matsuo, K.; Wunsch-Filho, V.; Toporcov, T. N.; de Carvalho, M. B.; La Vecchia, C.; Olshan, A. F.; Zevallos, J. P.; Serraino, D.; Muscat, J.; Sturgis, E. M.; Li, G.; Morgenstern, H.; Levi, F.; Dal Maso, L.; Smith, E.; Kelsey, K.; McClean, M.; Vaughan, T. L.; Lazarus, P.; Ramroth, H.; Chen, C.; Schwartz, S. M.; Winn, D. M.; Bosetti, C.; Edefonti, V.; Garavello, W.; Negri, E.; Hayes, R. B.; Purdue, M. P.; Boccia, S.; Cadoni, G.; Shangina, O.; Koifman, R.; Curado, M. P.; Vilensky, M.; Swiatkowska, B.; Herrero, R.; Franceschi, S.; Benhamou, S.; Fernandez, L.; Menezes, A. M. B.; Daudt, A. W.; Mates, D.; Schantz, S.; Yu, G. P.; Lissowska, J.; Brenner, H.; Fabianova, E.; Rudnai, P.; Brennan, P.; Boffetta, P.; Zhang, Z. F.; Hashibe, M.; Lee, Y. A. |
Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial |
journalArticle |
2018 |
Lebellec, L.; Bertucci, F.; Tresch-Bruneel, E.; Ray-Coquard, I.; Le Cesne, A.; Bompas, E.; Blay, J. Y.; Italiano, A.; Mir, O.; Ryckewaert, T.; Toiron, Y.; Camoin, L.; Goncalves, A.; Penel, N.; Le Deley, M. C. |
Telomere shortening: a new prognostic factor for cardiovascular disease post-radiation exposure |
journalArticle |
2015 |
M'Kacher, R.; Girinsky, T.; Colicchio, B.; Ricoul, M.; Dieterlen, A.; Jeandidier, E.; Heidingsfelder, L.; Cuceu, C.; Shim, G.; Frenzel, M.; Lenain, A.; Morat, L.; Bourhis, J.; Hempel, W. M.; Koscielny, S.; Paul, J. F.; Carde, P.; Sabatier, L. |
Reply to V.P. Retel et al, D. Gauchan et al, and C. Rahilly-Tierney et al |
journalArticle |
2015 |
Bonastre, J.; Marguet, S.; Lueza, B.; Michiels, S.; Delaloge, S.; Saghatchian, M. |
Hypofractionation for prostate cancer: a word of caution |
journalArticle |
2016 |
Bossi, A.; Blanchard, P. |
Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours |
journalArticle |
2016 |
Gizzi, M.; Oberic, L.; Massard, C.; Poterie, A.; Gwenael, L. T.; Loriot, Y.; Albiges, L.; Baciarello, G.; Michels, J.; Bossi, A.; Blanchard, P.; Escudier, B.; Fizazi, K. |
Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review |
journalArticle |
2015 |
Chouaïd, C.; Crequit, P.; Borget, I.; Vergnenegre, A. |
Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry |
journalArticle |
2019 |
Matejcic, M.; Saunders, E. J.; Dadaev, T.; Brook, M. N.; Wang, K.; Sheng, X.; Olama, A. A. A.; Schumacher, F. R.; Ingles, S. A.; Govindasami, K.; Benlloch, S.; Berndt, S. I.; Albanes, D.; Koutros, S.; Muir, K.; Stevens, V. L.; Gapstur, S. M.; Tangen, C. M.; Batra, J.; Clements, J.; Gronberg, H.; Pashayan, N.; Schleutker, J.; Wolk, A.; West, C.; Mucci, L.; Kraft, P.; Cancel-Tassin, G.; Sorensen, K. D.; Maehle, L.; Grindedal, E. M.; Strom, S. S.; Neal, D. E.; Hamdy, F. C.; Donovan, J. L.; Travis, R. C.; Hamilton, R. J.; Rosenstein, B.; Lu, Y. J.; Giles, G. G.; Kibel, A. S.; Vega, A.; Bensen, J. T.; Kogevinas, M.; Penney, K. L.; Park, J. Y.; Stanford, J. L.; Cybulski, C.; Nordestgaard, B. G.; Brenner, H.; Maier, C.; Kim, J.; Teixeira, M. R.; Neuhausen, S. L.; De Ruyck, K.; Razack, A.; Newcomb, L. F.; Lessel, D.; Kaneva, R.; Usmani, N.; Claessens, F.; Townsend, P. A.; Gago-Dominguez, M.; Roobol, M. J.; Menegaux, F.; Khaw, K. T.; Cannon-Albright, L. A.; Pandha, H.; Thibodeau, S. N.; Schaid, |
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial |
journalArticle |
2018 |
Bahig, H.; Yuan, Y.; Mohamed, A. S. R.; Brock, K. K.; Ng, S. P.; Wang, J.; Ding, Y.; Hutcheson, K.; McCulloch, M.; Balter, P. A.; Lai, S. Y.; Al-Mamgani, A.; Sonke, J. J.; van der Heide, U. A.; Nutting, C.; Li, X. A.; Robbins, J.; Awan, M.; Karam, I.; Newbold, K.; Harrington, K.; Oelfke, U.; Bhide, S.; Philippens, M. E. P.; Terhaard, C. H. J.; McPartlin, A. J.; Blanchard, P.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Phan, J.; Cazoulat, G.; Aristophanous, M.; McSpadden, K. K.; Garcia, J. A.; van den Berg, C. A. T.; Raaijmakers, C. P. J.; Kerkmeijer, L.; Doornaert, P.; Blinde, S.; Frank, S. J.; Fuller, C. D. |
Follow-up of differentiated thyroid cancer - what should (and what should not) be done |
journalArticle |
2018 |
Lamartina, L.; Grani, G.; Durante, C.; Borget, I.; Filetti, S.; Schlumberger, M. |
A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and Kyphoplasty |
journalArticle |
2015 |
Martelli, N.; Devaux, C.; van den Brink, H.; Pineau, J.; Prognon, P.; Borget, I. |
Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial |
journalArticle |
2017 |
Belin, L.; Kamal, M.; Mauborgne, C.; Plancher, C.; Mulot, F.; Delord, J. P.; Gonçalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Trédan, O.; Ricci, F.; Alt, M.; Loirat, D.; Sablin, M. P.; Paoletti, X.; Servois, V.; Le Tourneau, C. |
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead |
journalArticle |
2015 |
Minard-Colin, V.; Brugières, L.; Reiter, A.; Cairo, M. S.; Gross, T. G.; Woessmann, W.; Burkhardt, B.; Sandlund, J. T.; Williams, D.; Pillon, M.; Horibe, K.; Auperin, A.; Le Deley, M. C.; Zimmerman, M.; Perkins, S. L.; Raphael, M.; Lamant, L.; Klapper, W.; Mussolin, L.; Poirel, H. A.; Macintyre, E.; Damm-Welk, C.; Rosolen, A.; Patte, C. |
Modalités de surveillance des patients suivis pour un cancer de la prostate avancé : résultats d’une enquête nationale de pratique |
journalArticle |
2016 |
Rozet, F.; Roupret, M.; Hennequin, C.; Massard, C.; Blanchard, P.; Le moulec, S. |
[Individualization of dose and fractionation of radiotherapy for head and neck cancers] |
journalArticle |
2019 |
Blanchard, P.; Biau, J.; Castelli, J.; Tao, Y.; Graff, P.; Nguyen, F. |
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study |
journalArticle |
2016 |
Massard, C.; Oulhen, M.; Le Moulec, S.; Auger, N.; Foulon, S.; Abou-Lovergne, A.; Billiot, F.; Valent, A.; Marty, V.; Loriot, Y.; Fizazi, K.; Vielh, P.; Farace, F. |
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma |
journalArticle |
2015 |
Izzedine, H.; Derosa, L.; Le Teuff, G.; Albiges, L.; Escudier, B. |
Results of external beam radiotherapy for diffuse choroidal hemangiomas in Sturge-Weber syndrome |
journalArticle |
2018 |
Randon, M.; Lévy-Gabriel, C.; Abbas, R.; Dendale, R.; Lumbroso, L.; Desjardins, L.; Cassoux, N. |
Outcomes and prognostic factors for squamous cell carcinoma of the oral tongue in young adults: a single-institution case-matched analysis |
journalArticle |
2017 |
Blanchard, P.; Belkhir, F.; Temam, S.; El Khoury, C.; De Felice, F.; Casiraghi, O.; Patrikidou, A.; Mirghani, H.; Levy, A.; Even, C.; Gorphe, P.; Nguyen, F.; Janot, F.; Tao, Y. |
How to Reliably Assess Nodal Status in Distal Pancreatectomy for Adenocarcinoma |
journalArticle |
2018 |
Faron, M.; Vuarnesson, H.; Boher, J. M.; Bachellier, P.; Sauvanet, A.; Sa Cunha, A.; Le Treut, Y. P.; Mabrut, J. Y.; Delpero, J. R.; Paye, F. |
Relationship Between Carfilzomib Dose and Efficacy Outcomes in Patients With Relapsed and/or Refractory Multiple Myeloma |
journalArticle |
2015 |
Squifflet, P.; Michiels, S.; Siegel, D.; Vij, R.; Jagannath, S.; Saad, E. D.; Rajangam, K.; Ro, S. K.; Buyse, M. |
Late toxicity of brachytherapy after female genital tract tumors treated during childhood: Prospective evaluation with a long-term follow-up |
journalArticle |
2015 |
Levy, A.; Martelli, H.; Fayech, C.; Minard-Colin, V.; Dumas, I.; Gensse, M. C.; Le Deley, M. C.; Oberlin, O.; Haie-Meder, C. |
[Prophylactic nodal radiotherapy in prostate cancer] |
journalArticle |
2019 |
Bourdais, R.; Achkar, S.; Chauffert-Yvart, L.; Pasquier, D.; Sargos, P.; Blanchard, P.; Latorzeff, I. |
Prevalence of burnout, depression and job satisfaction among French senior and resident radiation oncologists |
journalArticle |
2018 |
Lazarescu, I.; Dubray, B.; Joulakian, M. B.; Blanchard, P.; Chauvet, B.; Mahe, M. A.; Mornex, F.; Rocher, F.; Thureau, S. |
Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells |
journalArticle |
2016 |
Mittal, D.; Caramia, F.; Michiels, S.; Joensuu, H.; Kellokumpu-Lehtinen, P. L.; Sotiriou, C.; Loi, S.; Smyth, M. J. |
Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives |
journalArticle |
2015 |
Mirghani, H.; Amen, F.; Blanchard, P.; Moreau, F.; Guigay, J.; Hartl, D. M.; Lacau St Guily, J. |
Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe |
journalArticle |
2015 |
Bölling, T.; Braun-Munzinger, G.; Burdach, S.; Calaminus, G.; Craft, A.; Delattre, O.; Deley, M. C.; Dirksen, U.; Dockhorn-Dworniczak, B.; Dunst, J.; Engel, S.; Faldum, A.; Fröhlich, B.; Gadner, H.; Göbel, U.; Gosheger, G.; Hardes, J.; Hawkins, D. S.; Hjorth, L.; Hoffmann, C.; Kovar, H.; Kruseova, J.; Ladenstein, R.; Leuschner, I.; Lewis, I. J.; Oberlin, O.; Paulussen, M.; Potratz, J.; Ranft, A.; Rössig, C.; Rübe, C.; Sauer, R.; Schober, O.; Schuck, A.; Timmermann, B.; Tirode, F.; van den Berg, H.; van Valen, F.; Vieth, V.; Willich, N.; Winkelmann, W.; Whelan, J.; Womer, R. B. |
Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience |
journalArticle |
2016 |
Bluthgen, M. V.; Boutros, C.; Fayard, F.; Remon, J.; Planchard, D.; Besse, B. |
Underuse of self-controlled designs in pharmacoepidemiology in electronic healthcare databases: a systematic review |
journalArticle |
2016 |
Gault, N.; Castaneda-Sanabria, J.; Guillo, S.; Foulon, S.; Tubach, F. |
French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours: Perspective For Future Trends |
journalArticle |
2015 |
Chouaid, C.; Borget, I.; Braun, E.; Bazil, M.; Schaetz, D.; Rémuzat, C.; Toumi, M. |
Strategies for Managing Intraoperative Discovery of Limited Colorectal Peritoneal Metastases |
journalArticle |
2019 |
Mariani, A.; Gelli, M.; Sourrouille, I.; Benhaim, L.; Faron, M.; Honore, C.; Elias, D.; Goere, D. |
Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study |
journalArticle |
2018 |
Aubrun, F.; Zahr, N.; Langeron, O.; Boccheciampe, N.; Cozic, N.; Belin, L.; Hulot, J. S.; Khiami, F.; Riou, B. |
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study |
journalArticle |
2016 |
Massard, C.; Oulhen, M.; Le Moulec, S.; Auger, N.; Foulon, S.; Abou-Lovergne, A.; Billiot, F.; Valent, A.; Marty, V.; Loriot, Y.; Fizazi, K.; Vielh, P.; Farace, F. |
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines? |
journalArticle |
2018 |
Watson, S.; Menis, J.; Baldini, C.; Martin-Romano, P.; Michot, J. M.; Hollebecque, A.; Armand, J. P.; Massard, C.; Soria, J. C.; Postel-Vinay, S.; Paoletti, X. |
Pharmacological modulation of radiation-induced oral mucosal complications |
journalArticle |
2018 |
Bockel, S.; Vallard, A.; Levy, A.; Francois, S.; Bourdis, M.; Le Gallic, C.; Riccobono, D.; Annede, P.; Drouet, M.; Tao, Y.; Blanchard, P.; Deutsch, E.; Magne, N.; Chargari, C. |
Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice |
journalArticle |
2016 |
Michiels, S.; Ternes, N.; Rotolo, F. |